The region's Y-o-Y increase in diabetes prevalence and the population's increased focus on optimal diabetes management treatment are significantly accelerating the growth of the APAC insulin pump market. According to data from the, an estimated 80 million people in Southeast Asia had diabetes in 2017; by 2045, this figure is expected to rise to 151 million. Diabetes affects 10% of China's adult population, according to the World Health Organisation. The adult population in India has a diabetes prevalence of 72.96 million.

Asia Pacific Insulin Pump Market Report Scope and Research Methodology

The report analyses the Asia Pacific Insulin Pump market size, growth, supply, demand, share, innovations, and recent developments, and key stakeholders can use the simple statistics, tables, and figures for strategic planning that leads to the organization's success. The report includes a detailed competitive landscape analysis of the Asia Pacific Insulin Pump market, as well as Company Profile, Revenue, Product Specifications, Production Capacity/Sales, Price, and Gross Margin Sales. The value of the and regional Asia Pacific Insulin Pump markets was estimated using the bottom-up approach. The information gathered using both methods The primary and secondary research methodologies were combined to create an authentic and error-free market report. In order to obtain an accurate Asia Pacific Insulin Pump market size, the analyst obtained these figures from Asia Pacific Insulin Pump industry experts and company representatives and externally validated them by analysing historical data of these product types and applications. SWOT analysis and Porter's Five Force Analysis are used to define, characterise, and analyse the Asia Pacific Insulin Pump market competition landscape, with a focus on key players.

Asia Pacific Insulin Pump Market Overview:

Stellar Market Research offers a summary of the Asia Pacific Insulin Pump Market as well as the most recent market snapshots. This aids comprehension of its features by providing an overview of the Asia Pacific Insulin Pump market that highlights common topics. This overview helps clients understand the situation in the Asia Pacific Insulin Pump Market industry.

Asia Pacific Insulin Pump Market Size is estimated to grow at a CAGR of 17.2% during the forecast period. Asia Pacific Insulin Pump Market is expected to reach US$ 1.99 Bn. in 2027 from US$ 0.77 Bn in 2021.

To Get A Copy Of The Sample Of The Market, Click Here:

Asia Pacific Insulin Pump Market Regional Insights:

The report assists clients in understanding the Asia Pacific Insulin Pump market structure by providing detailed information on key players in each key country. It is a clear representation of local energy, economic, political, and geographic variables that is required for any meaningful evaluation of potential policy options in response to the development of each region's Asia Pacific Insulin Pump market. North America, Asia Pacific, Europe, South America, the Middle East, and Africa are all covered in the report.

Asia Pacific Insulin Pump Market Dynamics:

A lack of focus on improving healthcare services, as well as limited access to technological advancements, may limit the growth of Technological advancements are another important factor driving market growth. "Medtronic has maintained its position as the primary market player in Asia-Pacific due to its invention in technological improvements, offering the patient in need, and implementing combined agreements," for example. The Asia-Pacific insulin pump market is expected to grow faster during the forecast period due to fierce competition from local market competitors.

Asia Pacific Insulin Pump Market Segmentation:

Pumps and Consumables are the two product types in the Asia Pacific Insulin Pump Market. Because of the advantages of pumps over multiple daily injections, continuous glucose monitors, and other devices, the pumps sector accounted for the largest market share. As a result, the use of these pumps in developed countries is rapidly increasing. According to Tandem's chief strategy officer, Elizabeth Gasser, the use of pumps among type diabetes patients worldwide is increasing with market penetration in APAC, reaching approximately 40 by 2027. Because these pumps are becoming more widely used internationally, the consumables section is expected to grow significantly during the forecast period. There is a higher demand for consumables. Consumables are becoming increasingly popular in various parts of the world due to a variety of factors such as their lower relative cost, ease of availability, and shorter replacement cycles for products such as infusion sets, batteries, and insulin vials compared to pumps.

The Asia Pacific Insulin Pump market is divided into two segments based on distribution channel: Hospital Pharmacy and Retail & Online Pharmacy. Because of the increased availability of diabetes management devices and solutions in retail and pharmaceutical outlets in both developing and developed countries, the retail & online pharmacy segment led the market with a sizable share. The majority of customers prefer to purchase these devices from pharmacies affiliated with hospitals, which explains the growth of the hospital pharmacy industry. Another factor is the expansion of reimbursement programmes for consumables such as pumps.

Asia Pacific Insulin Pump Market Key Players:
Sooil Development Co. (Korea)
Nipro Diagnostic, Inc. (Japan)
Diabetic Insulin Pump India (India)
Tandem Diabetes Care (U.S.)
Cellnovo Ltd (U.K.)
Ypsomes (Switzerland)

Key questions answered in the Asia Pacific Insulin Pump Market are:

  • What is Asia Pacific Insulin Pump Market?
  • What are the Asia Pacific Insulin Pump Market segments?
  • Which Asia Pacific Insulin Pump market segment is expected to grow at a high rate during the forecast period?
  • Who are the top players in the Asia Pacific Insulin Pump market industry?
  • What is the expected Asia Pacific Insulin Pump Market size by 2029?
  • What was the Asia Pacific Insulin Pump Market size in 2021?
  • Which region is expected to grow at a high CAGR?
  • Who held the largest market share in Asia Pacific Insulin Pump Market?

Key Offerings:

  • Past Market Size and Competitive Landscape (2018 to 2021)
  • Past Pricing and price curve by region (2018 to 2021)
  • Market Size, Share, Size & Forecast by different segment | 2022−2029
  • Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
  • Market Segmentation – A detailed analysis of segments and sub-segments
  • Competitive Landscape – Profiles of selected key players by region from a strategic perspective
  • PESTLE Analysis
  • PORTER’s analysis
  • Value chain and supply chain analysis
  • Legal Aspects of business by region
  • Lucrative business opportunities with SWOT analysis
  • Recommendations

Request for Free Sample Pages:

About Stellar Market Research

Established in 2018, Stellar Market Research is India Based consulting and advisory firm focused on helping clients to reach their business transformation objectives with advisory services and strategic business. The company’s vision is to be an integral part of the client’s business as a strategic knowledge partner. Stellar Market Research provides end-to-end solutions that go beyond key research technologies to help executives in any organization achieve their mission-critical goals. The company has clients from all across the globe, 23 % from India and others from Japan, Korea, Germany, United States, etc. The company uses its extensive industry knowledge, strong network, and know-how to provide complete insights that give clients a competitive advantage.

Contact Stellar Market Research, 4-8 Pl.7/4, Kothrud,

Pinnac Memories Fl. No. 3, Kothrud,

Pune, Maharashtra, 411029

[email protected]

+91 20 6630 3320    +91 9607365656